Education
About Us
Working with TipRanks
Follow Us
Brii Biosciences Limited (HK:2137)
:2137
RESEARCH TOOLSreports
Total Valuation
Brii Biosciences Limited has a market cap or net worth of €1.61B. The enterprise value is HK$3.53B.
Market Cap€1.61B
Enterprise ValueHK$3.53B
Share Statistics
Brii Biosciences Limited has 731,980,500 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding731,980,500
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Brii Biosciences Limited’s return on equity (ROE) is -0.19 and return on invested capital (ROIC) is -15.17%.
Return on Equity (ROE)-0.19
Return on Assets (ROA)-0.19
Return on Invested Capital (ROIC)-15.17%
Return on Capital Employed (ROCE)-0.15
Revenue Per Employee553.94K
Profits Per Employee-5.23M
Employee Count98
Asset Turnover0.02
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Brii Biosciences Limited is -1.32. Brii Biosciences Limited’s PEG ratio is 0.11.
PE Ratio-1.32
PS Ratio0.00
PB Ratio1.47
Price to Fair Value0.25
Price to FCF-7.41
Price to Operating Cash Flow-9.49
PEG Ratio0.11
Income Statement
In the last 12 months, Brii Biosciences Limited had revenue of 54.29M and earned -508.16M in profits. Earnings per share was -0.70.
Revenue54.29M
Gross Profit54.29M
Operating Income-399.50M
Pretax Income-512.38M
Net Income-508.16M
EBITDA-392.51M
Earnings Per Share (EPS)-0.70
Cash Flow
In the last 12 months, operating cash flow was -225.79M and capital expenditures -765.00K, giving a free cash flow of -226.55M billion.
Operating Cash Flow-225.79M
Free Cash Flow-226.55M
Free Cash Flow per Share-0.31
Dividends & Yields
Brii Biosciences Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.52
52-Week Price Change80.53%
50-Day Moving Average1.87
200-Day Moving Average1.42
Relative Strength Index (RSI)56.91
Average Volume (3m)3.47M
Important Dates
Brii Biosciences Limited upcoming earnings date is Aug 20, 2025, TBA Not Confirmed.
Last Earnings DateMar 21, 2025
Next Earnings DateAug 20, 2025
Ex-Dividend Date―
Financial Position
Brii Biosciences Limited as a current ratio of 31.18, with Debt / Equity ratio of 0.40%
Current Ratio31.18
Quick Ratio31.18
Debt to Market Cap0.03
Net Debt to EBITDA2.48
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Brii Biosciences Limited has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Brii Biosciences Limited EV to EBITDA ratio is 0.77, with an EV/FCF ratio of 0.00.
EV to Sales-5.59
EV to EBITDA0.77
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00
Balance Sheet
Brii Biosciences Limited has €2.33B in cash and marketable securities with ¥28.02M in debt, giving a net cash position of -€2.30B billion.
Cash & Marketable Securities€2.33B
Total Debt¥28.02M
Net Cash-€2.30B
Net Cash Per Share-€3.15
Tangible Book Value Per Share€3.32
Margins
Gross margin is 100.00%, with operating margin of -735.92%, and net profit margin of -936.08%.
Gross Margin100.00%
Operating Margin-735.92%
Pretax Margin-943.85%
Net Profit Margin-936.08%
EBITDA Margin-723.05%
EBIT Margin-735.92%
Analyst Forecast
The average price target for Brii Biosciences Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-100.00%
EPS Growth Forecast-176.44%